Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY 2024-10-29 06:32
Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults 2024-06-18 17:41
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort 2024-04-08 17:19
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) 2023-12-29 07:30
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate 2023-12-13 07:42
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil 2023-11-07 08:00
1